Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
AI Software Which Helps Diagnose Lung Cancer Receives Gov Funding Boost
New AI software to help better diagnose lung cancer has received major government funding. Lung […]
‘World First’ Online Cancer Recovery Platform Launched
A “world-first” online platform providing access to multidisciplinary cancer teams has been launched to support […]
Skanska Builds Municipal Health Lab in Harlem, New York for USD 448M
Skanska has signed a contract with the New York City Economic Development Corporation (NYCEDC) to […]
Swedish Company Announces New Product VirusShield, A Self-Adhesive Antimicrobial Protection Film That Kills Germs
Everyone needs to play their role in the struggle to end the global pandemic and […]
Olive Hits a $4 Billion Valuation with $400 Million of Capital Led by Vista Equity Partners
Olive, the automation company creating the Internet of Healthcare, announced today it closed a $400 million funding […]
UK Exceeds 600,000 COVID-19 Tests Genomically Sequenced
The UK has today (Friday 2 July) surpassed another important milestone in the fight against […]
Atara Biotherapeutics Joins the Rare Disease Company Coalition Alongside Industry Gamechangers
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell […]
Transine Therapeutics Appoints Industry Veteran Jan Thirkettle Ph.D. as CEO
Transine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its […]
MHRA Puts Delivering for Patients at the Heart of its Delivery Plan 2021-2023
A new and ambitious Delivery Plan centred on putting patients first, has been published today […]
NHS Chief Hails ‘Unprecedented’ Honour For Staff
Sir Simon Stevens today hailed the “skill and compassion and the fortitude” of health service […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more